RUNX3 and asthma: The inhibition of miR-145-5p in T CD4+ cells from patients with asthma promoted an enhanced percentage of IFN-γ+ CD4+ T cells by regulation of RUNX3 [61]; thus, miR-145-5p can modulate the Th1/th2 balance in asthma (Figure 2b).